Author: R. P. T. Davenport-Hines
Publisher: Cambridge University Press
ISBN: 9780521415392
Category : Business & Economics
Languages : en
Pages : 438
Book Description
This 1992 study of Glaxo, from its beginnings to 1962, examines the global operations of this pharmaceutical company.
Glaxo
Author: R. P. T. Davenport-Hines
Publisher: Cambridge University Press
ISBN: 9780521415392
Category : Business & Economics
Languages : en
Pages : 438
Book Description
This 1992 study of Glaxo, from its beginnings to 1962, examines the global operations of this pharmaceutical company.
Publisher: Cambridge University Press
ISBN: 9780521415392
Category : Business & Economics
Languages : en
Pages : 438
Book Description
This 1992 study of Glaxo, from its beginnings to 1962, examines the global operations of this pharmaceutical company.
Wealth Creation in the World’s Largest Mergers and Acquisitions
Author: B. Rajesh Kumar
Publisher: Springer
ISBN: 303002363X
Category : Business & Economics
Languages : en
Pages : 341
Book Description
This book highlights research-based case studies in order to analyze the wealth created in the world’s largest mergers and acquisitions (M&A). This book encourages cross fertilization in theory building and applied research by examining the links between M&A and wealth creation. Each chapter covers a specific case and offers a focused clinical examination of the entire lifecycle of M&A for each mega deal, exploring all aspects of the process. The success of M&A are analyzed through two main research approaches: event studies and financial performance analyses. The event studies examine the abnormal returns to the shareholders in the period surrounding the merger announcement. The financial performance studies examine the reported financial results of acquirers before and after the acquisition to see whether financial performance has improved after merger. The relation between method of payment, premium paid and stock returns are examined. The chapters also discuss synergies of the deal-cost and revenue synergies. Mergers and acquisitions represent a major force in modern financial and economic environment. Whether in times of boom or bust, M&As have emerged as a compelling strategy for growth. The biggest companies of modern day have all taken form through a series of restructuring activities like multiple mergers. Acquisitions continue to remain as the quickest route companies take to operate in new markets and to add new capabilities and resources. The cases covered in this book highlights high profile M&As and focuses on the wealth creation for shareholders of acquirer and target firms as a financial assessment of the merger’s success. The book should be useful for finance professionals, corporate planners, strategists, and managers.
Publisher: Springer
ISBN: 303002363X
Category : Business & Economics
Languages : en
Pages : 341
Book Description
This book highlights research-based case studies in order to analyze the wealth created in the world’s largest mergers and acquisitions (M&A). This book encourages cross fertilization in theory building and applied research by examining the links between M&A and wealth creation. Each chapter covers a specific case and offers a focused clinical examination of the entire lifecycle of M&A for each mega deal, exploring all aspects of the process. The success of M&A are analyzed through two main research approaches: event studies and financial performance analyses. The event studies examine the abnormal returns to the shareholders in the period surrounding the merger announcement. The financial performance studies examine the reported financial results of acquirers before and after the acquisition to see whether financial performance has improved after merger. The relation between method of payment, premium paid and stock returns are examined. The chapters also discuss synergies of the deal-cost and revenue synergies. Mergers and acquisitions represent a major force in modern financial and economic environment. Whether in times of boom or bust, M&As have emerged as a compelling strategy for growth. The biggest companies of modern day have all taken form through a series of restructuring activities like multiple mergers. Acquisitions continue to remain as the quickest route companies take to operate in new markets and to add new capabilities and resources. The cases covered in this book highlights high profile M&As and focuses on the wealth creation for shareholders of acquirer and target firms as a financial assessment of the merger’s success. The book should be useful for finance professionals, corporate planners, strategists, and managers.
Glaxo
Author: Julia Millen
Publisher: Glaxo Wellcome New Zealand
ISBN: 9780473043018
Category : Food industry and trade
Languages : en
Pages : 180
Book Description
Publisher: Glaxo Wellcome New Zealand
ISBN: 9780473043018
Category : Food industry and trade
Languages : en
Pages : 180
Book Description
The Sphere
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 508
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 508
Book Description
Mega Mergers and Acquisitions
Author: B. Kumar
Publisher: Springer
ISBN: 1137005904
Category : Business & Economics
Languages : en
Pages : 151
Book Description
A casebook that discusses all the mega mergers and acquisitions in terms of value, that have happened in different industry sectors such as pharmacy, technology, telecommunications, media and entertainment, electrical and electronics, energy, finance, consumer goods, metals, and automobile and airlines.
Publisher: Springer
ISBN: 1137005904
Category : Business & Economics
Languages : en
Pages : 151
Book Description
A casebook that discusses all the mega mergers and acquisitions in terms of value, that have happened in different industry sectors such as pharmacy, technology, telecommunications, media and entertainment, electrical and electronics, energy, finance, consumer goods, metals, and automobile and airlines.
The Graphic
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 474
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 474
Book Description
Punch
Author: Mark Lemon
Publisher:
ISBN:
Category : Caricatures and cartoons
Languages : en
Pages : 854
Book Description
Publisher:
ISBN:
Category : Caricatures and cartoons
Languages : en
Pages : 854
Book Description
Making Transnationals Accountable
Author: David Bailey
Publisher: Routledge
ISBN: 1134915438
Category : Business & Economics
Languages : en
Pages : 257
Book Description
With transnationals now of immense significance to many economies and thus seeming to have immense leverage over host governments, this book looks at what can be done to influence the behaviour of these corporations. With a case study of Glaxo.
Publisher: Routledge
ISBN: 1134915438
Category : Business & Economics
Languages : en
Pages : 257
Book Description
With transnationals now of immense significance to many economies and thus seeming to have immense leverage over host governments, this book looks at what can be done to influence the behaviour of these corporations. With a case study of Glaxo.
Medical Journal of Australia
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 814
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 814
Book Description
Norway's Pharmaceutical Revolution
Author: Knut Sogner
Publisher: Oxford University Press
ISBN: 0192869000
Category : Pharmaceutical industry
Languages : en
Pages : 273
Book Description
The pharmaceutical revolution that gathered pace in the 1930s delivered a plethora of almost magical new drugs such as penicillin, streptomycin, cortisone, and the birth control pill. This revolution grew from academic-business relationships in five countries: USA, Germany, Great Britain,Switzerland, and France. Many other countries tried and failed to replicate this success, yet a handful of Scandinavia companies made important breakthroughs in a narrow band of specialities. This is the story of how one Norwegian company-- Nyegaard and Co. --achieved international success from the1970s onwards with a breakthrough product facilitating X-ray pictures of the soft tissues of the body. The company succeeded by harnessing research skills and creating scientific and business alliances abroad, building its own momentum step by step: the corporation as entrepreneur. It thereby brokewith the conventional way a national medical ecosystem facilitated the crucial scientific progress. This is a story both of personal initiatives and great organizational transformations in several stages. In the 1950s, Nyegaard and Co. was a small hierarchical home market-oriented generics company.By the end of the 1990s, it had developed into a fairly large and multinational hierarchical company, preoccupied as much with shareholder value as scientific progress. It has also become a company that no longer had the same ability to innovate as before and therefore became merged into anotherone.
Publisher: Oxford University Press
ISBN: 0192869000
Category : Pharmaceutical industry
Languages : en
Pages : 273
Book Description
The pharmaceutical revolution that gathered pace in the 1930s delivered a plethora of almost magical new drugs such as penicillin, streptomycin, cortisone, and the birth control pill. This revolution grew from academic-business relationships in five countries: USA, Germany, Great Britain,Switzerland, and France. Many other countries tried and failed to replicate this success, yet a handful of Scandinavia companies made important breakthroughs in a narrow band of specialities. This is the story of how one Norwegian company-- Nyegaard and Co. --achieved international success from the1970s onwards with a breakthrough product facilitating X-ray pictures of the soft tissues of the body. The company succeeded by harnessing research skills and creating scientific and business alliances abroad, building its own momentum step by step: the corporation as entrepreneur. It thereby brokewith the conventional way a national medical ecosystem facilitated the crucial scientific progress. This is a story both of personal initiatives and great organizational transformations in several stages. In the 1950s, Nyegaard and Co. was a small hierarchical home market-oriented generics company.By the end of the 1990s, it had developed into a fairly large and multinational hierarchical company, preoccupied as much with shareholder value as scientific progress. It has also become a company that no longer had the same ability to innovate as before and therefore became merged into anotherone.